Management of fulminant botulism after allogeneic hematopoietic cell transplantation

Pediatr Blood Cancer. 2024 Nov;71(11):e31309. doi: 10.1002/pbc.31309. Epub 2024 Sep 3.

Authors

Nao Takasugi¹, Kaname Uchida¹, Konomi Shimoda¹, Eiichiro Watanabe², Shota Kato¹, Mitsuteru Hiwatari^{1

3}, Mahoko Ikeda⁴, Motohiro Kato¹, Hikoro Matsui¹

Affiliations

¹ Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
² Department of Pediatric Surgery, The University of Tokyo, Tokyo, Japan.
³ Department of Pediatrics, Teikyo University School of Medicine, Tokyo, Japan.
⁴ Department of Infectious Diseases, The University of Tokyo, Tokyo, Japan.

PMID: 39228072
DOI: 10.1002/pbc.31309

No abstract available

Publication types

Letter
Case Reports

MeSH terms

Botulism* / etiology
Botulism* / therapy
Child
Female
Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Male
Transplantation, Homologous